Quality of integrated female oncofertility care is suboptimal: A patient-reported measurement.

Autor: van den Berg M; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands., Kaal SEJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Dutch AYA 'Young and Cancer' Care Network, IKNL, Utrecht, the Netherlands., Schuurman TN; Center for Gynecologic Oncology Amsterdam, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Braat DDM; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands., Mandigers CMPW; Department of Medical Oncology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands., Tol J; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Tromp JM; Dutch AYA 'Young and Cancer' Care Network, IKNL, Utrecht, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands., van der Vorst MJDL; Department of Medical Oncology, Rijnstate Hospital, Arnhem, The Netherlands., Beerendonk CCM; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands., Hermens RPMG; Department of IQ Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands.
Jazyk: angličtina
Zdroj: Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 2691-2701. Date of Electronic Publication: 2022 Aug 29.
DOI: 10.1002/cam4.5149
Abstrakt: Background: Clinical practice guidelines recommend to inform female cancer patients about their infertility risks due to cancer treatment. Unfortunately, it seems that guideline adherence is suboptimal. In order to improve quality of integrated female oncofertility care, a systematic assessment of current practice is necessary.
Methods: A multicenter cross-sectional survey study in which a set of systematically developed quality indicators was processed, was conducted among female cancer patients (diagnosed in 2016/2017). These indicators represented all domains in oncofertility care; risk communication, referral, counseling, and decision-making. Indicator scores were calculated, and determinants were assessed by multilevel multivariate analyses.
Results: One hundred twenty-one out of 344 female cancer patients participated. Eight out of 11 indicators scored below 90% adherence. Of all patients, 72.7% was informed about their infertility, 51.2% was offered a referral, with 18.8% all aspects were discussed in counseling, and 35.5% received written and/or digital information. Patient's age, strength of wish to conceive, time before cancer treatment, and type of healthcare provider significantly influenced the scores of three indicators.
Conclusions: Current quality of female oncofertility care is far from optimal. Therefore, improvement is needed. To achieve this, improvement strategies that are tailored to the identified determinants and to guideline-specific barriers should be developed.
(© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje